According to a new report from the Global Cannabis Exchange (GCX), the Canadian cannabis market could become more volatile and competitive by 2026. The reasons? Rapid growth in supply, moderating domestic demand, and increasing international competition.

Researchers at the National Center for Agricultural Utilization Research (USDA) have identified compounds called dadahol A and dadahol B in the roots of industrial hemp. In laboratory tests, fractions containing these compounds reduced the viability of several pediatric cancer cell lines (including neuroblastoma, hepatoblastoma, and Hodgkin's lymphoma).

According to a study published in the medical journal Phytomedicine, CBD may have anti-tumor potential. The authors suggest that it increases pressure on certain cancer cells, limiting their ability to adapt. However, these results are preliminary and will need to be confirmed by further research, particularly in humans, before clinical applications can be considered.

US President Donald Trump has signed an executive order reclassifying cannabis from Schedule I—which includes substances considered most dangerous, such as heroin, LSD, and ecstasy—to Schedule III, alongside prescription drugs such as hydrocodone. This is a major step forward, marking a historic turning point since the United States introduced prohibition on the international stage nearly 100 years ago.

Starting February 1, 2026, the SQDC will extend the opening hours of 53 stores in the early evening on weekends. This measure is intended to better reflect customer traffic and habits, while optimizing operations. Stores will now close at 7 p.m. on Saturdays and 6 p.m. on Sundays.

President Donald Trump is reportedly poised to issue an executive order directing his administration to expedite the reclassification of cannabis as a Schedule 1 drug, following a meeting at the White House on December 10 with industry leaders.

With $337 million in revenue, cannabis ranks fifth among agricultural crops in Quebec. It represents an increasingly strategic diversification opportunity for farmers who want to innovate and strengthen the resilience of their businesses. To respond to this reality and train the next generation, Cégep Gérald-Godin has developed a program unique in Quebec dedicated to cannabis production and processing.

According to data from Weed Crawler, in just six days, the SQDC sold $1.4 million worth of cannabis vaping products, for a total of 39,000 cartridges. This represents a 14% increase in sales compared to the same period last year.

Ottawa and the provinces have collected more than $5.4 billion in cannabis taxes since legalization. Of this amount, $1.2 billion went to the federal government and $4.2 billion to the provinces. Ontario collected the most money, with a total of $1.5 billion.

On November 26, 2025, the Société québécoise du cannabis will begin marketing cannabis vaping products. Since 28% of Quebec consumers already use this method of consumption, this new offering aims to divert them from the illicit market and reduce the risks associated with unregulated products that are potentially harmful or dangerous.

The SQDC has just published its results for the second quarter of 2025-2026. The bottom line: net income of $30.5 million and $67.6 million in tax revenue (with $48.3 million paid to the Quebec government and $19.3 million to the federal government), including $59.9 million paid to the Addiction Fund to support prevention, research, and harm reduction related to psychoactive substances.

According to Statistics Canada data, in 2024, the country recorded a 31% drop in drug-related crime rates compared to 2019, the first full year of data following the legalization of non-medical cannabis.